Coronavirus vaccines: EU concludes discussions with Janssen Pharmaceutica
Share article:
Share article:

Coronavirus vaccines: EU concludes discussions with Janssen Pharmaceutica

© Belga

After having held discussions with the Sanofi-GSK pharmaceutical duo, the European Commission announced on Thursday that it had also concluded initial discussions with Janssen Pharmaceutica, the Belgian subsidiary of Johnson & Johnson.

The talks aim to reach a possible advance purchase contract that would guarantee EU member states a certain number of vaccine doses, in case the company manages to create an effective vaccine against the new coronavirus.

In parallel, the Commission also continues to discuss with other pharmaceutical companies which are trying to develop a vaccine. This is part of the Commission’s “vaccine strategy” unveiled in mid-June, to ensure that Europeans do not remain on the sidelines when an approved vaccine reaches the market.

The Commission presented then a common European strategy to buy vaccines against the coronavirus on behalf of all member states through advance purchase agreements with producers. In a complementary track, four EU member states had signed orders for millions of doses of a vaccine which is being developed by the British-Swedish pharmaceutical company AstraZeneca.

Concerns have been circulating, that the United States would try to monopolize potential future vaccine stocks.

The Commission has launched a sort of call for tenders to pharmaceutical companies, to centralize EU-level negotiations. While the commission is well aware that the successful development of a safe vaccine is not guaranteed, the idea is that the EU then agrees in advance to buy a certain number of doses at a pre-established price, with the producer promising to provide them, if their vaccine is validated and safe.

The Commission is financing part of the initial costs, but it will ultimately be down to each Member State to pay for the number of doses needed, based on the size of their populations.

With GSK-Sanofi, the Commission agreed on 31 July on a contractual framework allowing for the possible purchase of 300 million doses on behalf of all member states. Sanofi-GSK’s vaccine candidate is planning to seek marketing authorisation in June 2021, following Phase III clinical trials yielding the induction of a promising immune response.

With Johnson & Johnson, the Commission discusses a possible contract for 200 million doses, with the possibility of an additional 200 million in a second step, also on behalf of all member states.

The EU’s “vaccine strategy” specifies that it wants to ensure a large-scale availability of a vaccine for all Europeans in a time-frame of within a year to a year and a half.

The Brussels Times

Latest news

More politicians than ordinary citizens at the Conference on the Future of Europe
The second Plenary of the Conference took place on Saturday in the European Parliament in Strasbourg and discussed the contributions from the ...
Belgium’s Consultative Committee to meet on Tuesday
The next meeting of Belgium's Consultative Committee, scheduled for Friday, has been brought forward to Tuesday at 4:30 PM, according to local media ...
Coca-Cola, Pepsi and Unilever are world’s biggest plastic polluters
Coca-Cola, Pepsi, and Unilever were found to be the world's biggest polluters of plastic in a report published by Branded on Monday. Over 11,000 ...
Four men charged with illegally buying thousands of live ducks to hunt on private land
Four Belgian men will appear in court on Monday facing charges related to the purchase of thousands of ducks, which were then released into a private ...
More wolf attacks: 15 deer killed at family resort over the weekend
Fifteen deer were killed by wolves in the Belgian province of Limburg this weekend, between Saturday night and Sunday morning. The deer were ...
Cost of breast cancer still too high for many patients
Breast cancer still carries too high a cost for patients when one in nine women in Belgium will face the disease before reaching 75, according to a ...
Gare Maritime: Brussels’ most exciting new architectural project
A generation ago, the Gare Maritime in the Tour & Taxis industrial site was an abandoned wasteland. It is now a model for urban renewal and ...
Belgium in Brief: Rules For A Fourth Wave
It's the news that nobody wants to hear, but here we go again. Belgium’s council of ministers will hold an emergency meeting on Monday to discuss ...
Belgian grandparents to walk across Scotland for COP26
A group of Belgian grandparents has set off on a 100 km hike that will take them from Belgium to the Scottish city of Glasgow, just ahead of the ...
Rise in fuel prices will bring Belgian State €547 million in tax, say Workers Party
The sharp rise in fuel prices that have been felt across the continent will bring an additional €547 million to the Belgian State, the Workers' Party ...
Amid backlash, Brussels police chief promises to do better for sexual assault victims
After multiple rallies against sexual violence took place in Brussels last week, with victims offering testimony of poor treatment from police when ...
Person hit by train in Brussels
A person was hit by a train in the tunnel between Brussels North and Brussels Central at around 10:20 AM on Monday, railway network manager Infrabel ...